Health
Immune checkpoint inhibitor efficacy against glioblastoma may decrease with dexamethasone – Science Codex
Bottom Line: Among patients with glioblastoma receiving an immune checkpoint inhibitor, those who received the corticosteroid dexamethasone at baseline for cerebral edema had significantly worse overall survival.
Journal in Which the Study was Published: Clinical Cancer Research, a journal of the American Association for Cancer Research
Author: David A. Reardon, MD, clinical director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute in Boston
Background: “Dexamethasone is a potent…
-
Noosa News24 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
Noosa News13 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News23 hours agoWoman loses arm in lion attack at Darling Downs Zoo in Queensland
-
General20 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76